Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial.

MLA

Packer, Milton, et al. “Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: The EMPEROR-Reduced Trial.” European Journal of Heart Failure, vol. 23, no. 9, Sept. 2021, pp. 1529–38. EBSCOhost, https://doi.org/10.1002/ejhf.2256.

APA

Packer, M., Januzzi, J. L., Ferreira, J. P., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Brueckmann, M., Jamal, W., Cotton, D., Iwata, T., & Zannad, F. (2021). Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial. European Journal of Heart Failure, 23(9), 1529–1538. https://doi.org/10.1002/ejhf.2256

Chicago

Packer, Milton, James L Januzzi, Joao Pedro Ferreira, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, et al. 2021. “Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: The EMPEROR-Reduced Trial.” European Journal of Heart Failure 23 (9): 1529–38. doi:10.1002/ejhf.2256.